Literature DB >> 8485954

Frequency and symptoms of hypoglycaemia experienced by patients with type 2 diabetes treated with insulin.

D A Hepburn1, K M MacLeod, A C Pell, I J Scougal, B M Frier.   

Abstract

This study ascertained the prevalence of severe hypoglycaemia and loss of awareness of hypoglycaemia in patients with Type 2 diabetes treated with insulin. One hundred and four sequentially selected Type 2 diabetic patients were compared with 104 patients with Type 1 diabetes who were matched for duration of insulin therapy. The patients were interviewed using a standardized questionnaire. During treatment with insulin, 18 Type 2 patients had experienced fewer than two episodes of hypoglycaemia, while 86 had experienced two or more episodes; 80 (93%) reported normal awareness, six (7%) reported partial awareness, and none had absent awareness of hypoglycaemia. All 86 Type 1 diabetic patients matched to the 86 Type 2 patients had experienced multiple episodes of hypoglycaemia; 71 (83%) had normal awareness, 14 (16%) had partial awareness and one patient (1%) reported absent awareness of hypoglycaemia. The Type 1 patients who had altered awareness of hypoglycaemia had longer duration of diabetes and insulin therapy (normal awareness: 5 (1-17) years (median (range)) vs partial awareness: 9 (3-18) years, p < 0.01). Similarly, Type 2 patients with altered awareness had longer duration of diabetes (normal awareness: 11 (2-25) years vs partial awareness: 19 (8-24) years, p < 0.02) and had received insulin for longer (normal awareness: 3 (1-18) years vs partial awareness: 12 (6-17) years, p < 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8485954     DOI: 10.1111/j.1464-5491.1993.tb00050.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  19 in total

Review 1.  Severe hypoglycemia in adults.

Authors:  Mary F Carroll; Mark R Burge; David S Schade
Journal:  Rev Endocr Metab Disord       Date:  2003-05       Impact factor: 6.514

Review 2.  Drug-induced disorders of glucose metabolism. Mechanisms and management.

Authors:  J C Chan; C S Cockram; J A Critchley
Journal:  Drug Saf       Date:  1996-08       Impact factor: 5.606

Review 3.  New concepts in diabetes mellitus. I: Treatment, pregnancy and aetiology.

Authors:  R Taylor; M Vanderpump
Journal:  Postgrad Med J       Date:  1994-06       Impact factor: 2.401

Review 4.  Benefits and risks of transfer from oral agents to insulin in type 2 diabetes mellitus.

Authors:  A Evans; A J Krentz
Journal:  Drug Saf       Date:  1999-07       Impact factor: 5.606

5.  Hypoglycaemic symptoms and hypoglycaemia threshold in older people with diabetes--a patient perspective.

Authors:  A H Abdelhafiz; C Bailey; B Eng Loo; A Sinclair
Journal:  J Nutr Health Aging       Date:  2013       Impact factor: 4.075

6.  Addition of vildagliptin to insulin improves glycaemic control in type 2 diabetes.

Authors:  V Fonseca; A Schweizer; D Albrecht; M A Baron; I Chang; S Dejager
Journal:  Diabetologia       Date:  2007-03-27       Impact factor: 10.122

7.  The impact of the angiotensin-converting enzyme insertion/deletion polymorphism on severe hypoglycemia in Type 2 diabetes.

Authors:  Rachel M Freathy; Kathryn F Lonnen; Anna M Steele; Jayne A L Minton; Timothy M Frayling; Andrew T Hattersley; Kenneth M Macleod
Journal:  Rev Diabet Stud       Date:  2006-08-10

8.  Severe hypoglycaemia and cognitive impairment in older patients with diabetes: the Fremantle Diabetes Study.

Authors:  D G Bruce; W A Davis; G P Casey; R M Clarnette; S G A Brown; I G Jacobs; O P Almeida; T M E Davis
Journal:  Diabetologia       Date:  2009-07-03       Impact factor: 10.122

Review 9.  Minimizing morbidity of hypoglycemia in diabetes: a review of mini-dose glucagon.

Authors:  Stephanie T Chung; Morey W Haymond
Journal:  J Diabetes Sci Technol       Date:  2014-08-26

Review 10.  Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications.

Authors:  Brian M Frier
Journal:  Nat Rev Endocrinol       Date:  2014-10-07       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.